Please Verify Your Age

Description

Product Overview

Tirzepatide is a synthetic dual GIP and GLP-1 receptor agonist peptide, often called a “twincretin” because it combines the activity of the two principal incretin hormones in a single acylated molecule. It has become a benchmark reference compound in incretin and metabolic research and is widely used to probe how combined gut-hormone signaling differs from GLP-1 activation alone.

Research Information

Tirzepatide is studied for how co-activation of the GIP and GLP-1 receptors affects glucose-dependent insulin secretion, gastric emptying, satiety-related neural pathways and adipose-tissue metabolism in cell and animal models. Investigators frequently use it as a comparator against GLP-1-only agonists to separate the contributions of the two receptors, and to examine its long half-life and receptor-binding kinetics. Supplied strictly for in-vitro and laboratory research use only — not for human or animal consumption.